PureTech Health plc (NASDAQ:PRTC – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $23.00, but opened at $22.08. PureTech Health shares last traded at $22.10, with a volume of 628 shares changing hands.
PureTech Health Trading Up 1.0 %
The firm has a 50-day moving average price of $24.39 and a 200 day moving average price of $26.00.
Hedge Funds Weigh In On PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. AWM Investment Company Inc. acquired a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 6,900 shares of the company’s stock, valued at approximately $197,000. Hedge funds and other institutional investors own 0.04% of the company’s stock.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Stories
- Five stocks we like better than PureTech Health
- Breakout Stocks: What They Are and How to Identify Them
- Brinker International’s Price Dip is an Appetizing Entry Point
- Options Trading – Understanding Strike Price
- 3 Stocks That Could Beat the September Blues
- Election Stocks: How Elections Affect the Stock Market
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.